The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.
In compliance with applicable State regulatory authorities, COVID-19 vaccination is mandatory for all MSK staff. Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 (i.e., one dose of a single dose vaccine or a final dose of a multi-dose vaccine series). Exceptions from the COVID-19 vaccine requirement are permitted for those who request and receive an approved medical or fully remote exemption. Requests for medical exemption can take up to two weeks to review. Vaccination or an approved medical exemption is required to start work.
Note: Individuals are eligible to receive a COVID-19 booster two months after completion of a primary vaccination series for COVID-19. Because vaccine-induced immunity can wane over time, MSK continues to strongly urge all staff to get a COVID-19 booster as soon as they become eligible to maintain their protective immunity for a longer period.
The Jones laboratory, a multi-R01 funded research program, in conjunction with the Druckenmiller Center for Lung Cancer Research, is searching for an outstanding post-doctoral candidate with a strong interest in translational research focused on the biology of lung cancer metastases. The Jones laboratory focuses on transcriptomic and genomic drivers of lung and esophageal cancer metastases. Other projects in the laboratory include leveraging a large, genomically annotated patient-derived organoid program (lung and esophageal cancer), and identification of new genomic predictors of lung cancer recurrence, among others. We are seeking candidates with a strong molecular and tumor biology background with experience in lung cancer tumor biology, xenograft and transgenic animal models of metastases, and the biology of metastases. The candidate will have the opportunity to interact with investigators with expertise in the biology of lung cancer, translational therapeutics, and molecular pathology.
The ideal candidate should have:
Please send CV, bibliography, brief statement of research interests and names of 3 references via email (Including #JonesResearch in the subject line) to:
Surgery Research Lab Manager, SKI
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.